SERPINF1 and cancer: Given that PEDF is the strongest endogenous anti-angiogenic factor that counteracts multiple pro-angiogenic factors including VEGF, the down-regulation of PEDF in cancer tissue could suggests a tilted balance toward over-angiogenic.